NASC (Nascent Pharma Holdings) Days Payable: 575.25 (As of Sep. 2024)

What is Nascent Pharma Holdings Days Payable?

Nascent Pharma Holdings NASC 12 Days Payable is 575.25 as of Sep. 2024. GuruFocus rates NASC with a GF Score™ of 12/100.

Nascent Pharma Holdings's average Accounts Payable for the three months ended in Sep. 2024 was $2.62 Mil. Nascent Pharma Holdings's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.42 Mil. Hence, Nascent Pharma Holdings's Days Payable for the three months ended in Sep. 2024 was 575.25.

The historical rank and industry rank for Nascent Pharma Holdings's Days Payable or its related term are showing as below:

NASC's Days Payable is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 90.98
* Ranked among companies with meaningful Days Payable only.

Nascent Pharma Holdings's Days Payable increased from Sep. 2023 (285.19) to Sep. 2024 (575.25). It may suggest that Nascent Pharma Holdings delayed paying its suppliers.

Nascent Pharma Holdings Days Payable Related Terms

Nascent Pharma Holdings Days Payable Historical Data

* Premium members only.

The historical data trend for Nascent Pharma Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nascent Pharma Holdings Days Payable Chart

Nascent Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

91.10

249.46

149.10

192.85

516.42

Nascent Pharma Holdings Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															285.19	0.00	161.01	334.74	575.25

NASC vs ALID, CPMD, PLSH: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Nascent Pharma Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nascent Pharma Holdings Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nascent Pharma Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Nascent Pharma Holdings's Days Payable falls into.

Save Embed

12GF Score

Nascent Pharma Holdings Inc NASC

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nascent Pharma Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Nascent Pharma Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (3.14	+	1.945)	/	2 )	/	1.797	*	365
=	2.5425					/	1.797	*	365
=	516.42

Nascent Pharma Holdings's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (2.614	+	2.631)	/	2 )	/	0.416	*	365 / 4
=	2.6225					/	0.416	*	365 / 4
=	575.25

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 575.25 mean?

Nascent Pharma Holdings (NASC) has a Days Payable of 575.25 as of Sep. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nascent Pharma Holdings and its competitors.

Is Nascent Pharma Holdings' Days Payable too high?

Nascent Pharma Holdings' current Days Payable is 575.25. The Drug Manufacturers industry median Days Payable is 90.98. Nascent Pharma Holdings' value of 575.25 is 532.3% above this industry median. Overall, Nascent Pharma Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Nascent Pharma Holdings' Days Payable compare to ALID and CPMD?

Nascent Pharma Holdings' Days Payable of 575.25 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.98. Nascent Pharma Holdings' value of 575.25 is 532.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Drug Manufacturers company?

The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nascent Pharma Holdings's current Days Payable of 575.25 is 532.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nascent Pharma Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nascent Pharma Holdings's current Days Payable is 575.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nascent Pharma Holdings stock overvalued right now?

Nascent Pharma Holdings (NASC) has a current Days Payable of 575.25. The current Days Payable is 575.25 and 532.3% above the Drug Manufacturers industry median of 90.98. Nascent Pharma Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Nascent Pharma Holdings (NASC), the current Days Payable is 575.25 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nascent Pharma Holdings Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ALID CPMD PLSH KAYS PTPI CBDY STEK NXEN UPC PRFX ZTS XTER:MRK TSE:4502 NSE:SUNPHARMA XSWX:GALD LSE:HLN HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506

Address 44 East End Avenue, Hicksville, NY, USA, 11801

Website https://nascentpharmaholdings.com

Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.

12GF Score

Get the complete analysis for NASC

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01

Price

View NASC Analysis

See Days Payable data for all stocks →